Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 2,165 | $135.08 | $292,448.20 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 7 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.84. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 2,165 | $79.94 | $173,070.10 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 6 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 2,549 | $135.08 | $344,318.92 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 5 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 2,549 | $69.03 | $175,957.47 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 200 | $137.91 | $27,582.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.88 to $137.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 4,200 | $136.96 | $575,232.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,200 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.29 to $137.06. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 2,027 | $135.09 | $273,827.43 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,400 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000920 · form4.xml · derivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 637 | $145.86 | $92,912.82 |
DisclosureSEC source: 0001127602-22-000920 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,363 Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:03 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000920 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 21:21 UTC |
Peterson JaclynVP of Mfg. & Adv. Engineering
|
GrantCommon Stock | 64 | $134.67 | $8,618.88 |
DisclosureSEC source: 0001127602-22-000862 · form4.xml · nonDerivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64 Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 21:13 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 14 | $134.67 | $1,885.38 |
DisclosureSEC source: 0001127602-22-000844 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 22:01 UTC |
Cohen Heather LEVP CORP HR
|
Other401 (K) Plan | 30.93 | $141.76 | $4,384.64 |
DisclosureSEC source: 0001127602-22-003988 · form5.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 4,935.71 F1 · date: As of December 31, 2021. F2 · balance_after: No change in holdings other than as a result of a change of stock in the 401(K) CONMED fund. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 22:06 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Other401 (K) Plan | 116.404 | $141.76 | $16,501.43 |
DisclosureSEC source: 0001127602-22-003990 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,201.026 F1 · date: As of December 31, 2021. F2 · balance_after: No change in holdings other than as a result of a change of stock in the 401(K) CONMED fund. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · derivative · entry 16 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,886 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · derivative · entry 15 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,886 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,399 | $0.00 Strike: $69.03 | $0.00 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · derivative · entry 14 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,399 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,892 | $0.00 Strike: $51.90 | $0.00 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · derivative · entry 13 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,892 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 100 | $157.05 | $15,705.00 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 12 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,296 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 1,743 | $156.48 | $272,749.87 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 11 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,396 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,843 | $73.94 | $136,271.42 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 10 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 500 | $156.95 | $78,474.50 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 9 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,296 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 2,386 | $156.44 | $373,256.30 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 8 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,796 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 2,886 | $79.94 | $230,706.84 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 7 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 500 | $157.06 | $78,530.50 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 6 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,296 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 2,899 | $156.44 | $453,516.66 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 5 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,796 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 3,399 | $69.03 | $234,632.97 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 4 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 100 | $157.11 | $15,711.00 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 3 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,296 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 4,792 | $156.51 | $749,986.34 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,396 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 01:59 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 4,892 | $51.90 | $253,894.80 |
DisclosureSEC source: 0001127602-21-028634 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:15 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,550 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-21-028439 · form4.xml · derivative · entry 7 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 2,550 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:15 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-21-028439 · form4.xml · derivative · entry 6 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Underlying: Common Stock · 5,400 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:15 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 2,550 | $154.62 | $394,268.25 |
DisclosureSEC source: 0001127602-21-028439 · form4.xml · nonDerivative · entry 5 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,634 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.53 to $154.64. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:15 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 2,550 | $97.69 | $249,109.50 |
DisclosureSEC source: 0001127602-21-028439 · form4.xml · nonDerivative · entry 4 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:15 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 5,400 | $154.56 | $834,624.00 |
DisclosureSEC source: 0001127602-21-028439 · form4.xml · nonDerivative · entry 3 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,634 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:15 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 5,400 | $78.76 | $425,304.00 |
DisclosureSEC source: 0001127602-21-028439 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:15 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 1,247 | $154.14 | $192,210.09 |
DisclosureSEC source: 0001127602-21-028439 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,634 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 16:41 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-21-028434 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Common Stock · 14,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 16:41 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 14,000 | $154.06 | $2,156,854.00 |
DisclosureSEC source: 0001127602-21-028434 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.58. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 16:41 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 14,000 | $39.87 | $558,180.00 |
DisclosureSEC source: 0001127602-21-028434 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 13:09 UTC |
Beyer PatPresident Int'l & Global Ortho
|
SaleCommon Stock | 6,497 | $149.20 | $969,345.90 |
DisclosureSEC source: 0001127602-21-028423 · form4.xml · nonDerivative · entry 3 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,807 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.02 to $149.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 13:09 UTC |
Beyer PatPresident Int'l & Global Ortho
|
SaleCommon Stock | 10,550 | $148.47 | $1,566,379.60 |
DisclosureSEC source: 0001127602-21-028423 · form4.xml · nonDerivative · entry 2 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 13:09 UTC |
Beyer PatPresident Int'l & Global Ortho
|
SaleCommon Stock | 400 | $147.51 | $59,002.00 |
DisclosureSEC source: 0001127602-21-028423 · form4.xml · nonDerivative · entry 1 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,854 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.95 to $147.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,700 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · derivative · entry 14 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,600 Underlying: Common Stock · 1,700 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,800 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · derivative · entry 13 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 Underlying: Common Stock · 1,800 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,100 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · derivative · entry 12 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,800 Underlying: Common Stock · 5,100 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 862 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · derivative · entry 11 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 862 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 1,700 | $148.60 | $252,613.20 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 10 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.10 to $148.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 1,700 | $97.69 | $166,073.00 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 9 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 872 | $148.31 | $129,328.94 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 8 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.02 to $148.59. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.